Liver disease : Wegovy injection is approved for MASH, a serious liver disease linked to fat buildup in the liver
Study 2 was a 68-week trial that enrolled 1,961 patients with obesity (BMI greater than or equal to 30 kg/m2) or with overweight (BMI 27 to 29.9 kg/m2) and at least one weight-related comorbid condition, such as treated or untreated dyslipidemia or hypertension
Reducing body fat can lower the risk of type 2 diabetes, heart disease, and certain cancers
Through these mechanisms, Epithalon supports deeper, more restorative sleep (3)
Epis R, Marcello E, Gardoni F, Longhi A, Calvani M, Iannuccelli M, et al
Will stopping Wegovy reverse sun sensitivity